Provention Bio Inc Asset Turnover Ratio (PRVB), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Provention Bio Inc   (NASDAQ: PRVB)
 

Provention Bio Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Provention Bio Inc asset turnover ratio, the ability of Provention Bio Inc 's assets to generate revenue in the fourth quarter 2022, increased sequentially to 0.08 in the fourth quarter (Dec 31 2022), a new company high.

Within sector 231 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2022 compared to the preceding quarter from 3495 to 4043.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRVB Asset Turnover Ratio (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Asset Change 74.65 % 23.46 % -43.07 % -42.72 % 5.53 %
Y / Y Revenue Change 1408.09 % 11.5 % - - -
Asset Turnover Ratio (TTM) 0.08 0.02 0.02 0.01 0.01
PRVB's Total Ranking # 4043 # 3495 # 4025 # 0 # 0
Seq. Asset Change 21.51 % 86.79 % -14.78 % -9.71 % -14.1 %
Seq. Revenue Change 1330.29 % 1.34 % 28.62 % -19.11 % 5.75 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 232
Healthcare Sector # 616
Overall Market # 4043

Asset Turnover Ratio Statistics
High Average Low
0.08 0.04 0.02
(Dec 31 2022)   (Sep 30 2022)




PRVB Company Profile • Back to PRVB Efficiency Comparisons • Compare PRVB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Athersys Inc  0.15 $ 5.325  Millions$ 35.859  Millions
Marinus Pharmaceuticals Inc   0.15 $ 25.478  Millions$ 173.637  Millions
Blueprint Medicines Corporation  0.15 $ 187.269  Millions$ 1,286.012  Millions
Somalogic Inc   0.14 $ 97.666  Millions$ 683.718  Millions
Invo Fertility Inc   0.14 $ 0.822  Millions$ 5.932  Millions
Sunshine Biopharma Inc   0.14 $ 4.346  Millions$ 31.377  Millions
Petvivo Holdings Inc   0.14 $ 0.847  Millions$ 6.157  Millions
Hcw Biologics Inc   0.14 $ 6.722  Millions$ 49.132  Millions
Ideaya Biosciences Inc   0.14 $ 50.931  Millions$ 373.938  Millions
Cyclo Therapeutics Inc   0.14 $ 1.376  Millions$ 10.117  Millions
Petros Pharmaceuticals inc   0.14 $ 5.992  Millions$ 44.258  Millions
Sqz Biotechnologies Company  0.14 $ 21.478  Millions$ 158.966  Millions
Mymetics Corporation  0.13 $ 1.114  Millions$ 8.289  Millions
Stimcell Energetics Inc   0.13 $ 0.005  Millions$ 0.042  Millions
Liquidia Corporation  0.13 $ 15.935  Millions$ 123.593  Millions
Royalty Pharma Plc  0.13 $ 2,237.215  Millions$ 17,401.343  Millions
Pulmatrix Inc   0.13 $ 6.071  Millions$ 47.776  Millions
Scisparc Ltd  0.13 $ 1.347  Millions$ 10.605  Millions
Biodexa Pharmaceuticals Plc  0.13 $ 0.699  Millions$ 5.525  Millions
Acutus Medical Inc   0.13 $ 16.363  Millions$ 129.510  Millions
Delcath Systems Inc   0.13 $ 2.719  Millions$ 21.618  Millions
Biocardia Inc   0.13 $ 1.352  Millions$ 10.770  Millions
Sigilon Therapeutics Inc   0.12 $ 12.944  Millions$ 103.870  Millions
Fate Therapeutics Inc   0.12 $ 96.300  Millions$ 780.089  Millions
Genfit S a   0.12 $ 29.754  Millions$ 241.405  Millions
Regenxbio Inc   0.12 $ 112.724  Millions$ 923.968  Millions
2seventy Bio Inc   0.12 $ 91.496  Millions$ 751.184  Millions
Intercure Ltd   0.12 $ 115.951  Millions$ 958.007  Millions
Universal Biosensors Inc   0.12 $ 4.525  Millions$ 37.414  Millions
Alpine Immune Sciences Inc   0.12 $ 30.064  Millions$ 257.012  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.